Workflow
亿帆医药:柯泰亚是公司合成生物项目研发的重要战略合作伙伴之一

Core Viewpoint - The company is focusing on developing synthetic biological products and has made significant investments in its production capabilities, indicating a strategic shift towards in-house manufacturing and innovation [2]. Group 1: Investment and Production - The company has invested 1 billion yuan in building a new factory in Qidong City, which suggests a potential decision to move away from collaboration with Xinfu [2]. - The company aims to provide natural, green, and sustainable innovative products across various markets, including healthcare, human and animal nutrition, and pharmaceuticals [2]. Group 2: Collaboration and Future Plans - There are questions regarding the future of existing collaborations on products such as Ectoin, Farnesol, and Fucoidan, particularly whether these partnerships will end after their current terms [2].